报价延迟最少15分钟:2025/11/20 18:40 EST
盘后时段
|
||||
|
11.82 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
11.82
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.99/--
|
|
企业价值
331.59M
|
| 资产负债 |
|
每股账面净值
4.01
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
13.78M
|
|
每股收益
--
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/11/20 18:40 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures. |
